VSTM
VSTM
NASDAQ · Biotechnology

Verastem Inc

$6.19
+0.28 (+4.74%)
As of Aug 8, 1:54 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +127.0% upside
Low Target $11.84
Average Target $14.05
High Target $17.49
Current Price $6.19
Current
$6.19
Target
$14.05
$11.84 $14.05 avg $17.49
Scenario Analysis
Bear Case
$11.84
91.3%
Low target
Base Case
$14.05
+127.0%
Avg target
Bull Case
$17.49
+182.6%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$11.25
-45.0% from high
52-Week Low
$3.43
+80.5% from low
Target vs 52W High
$14.05
+24.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%